Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131342) titled 'Clinical research on molecular probes targeting neurotensin receptor 1 (NTSR1)' on Sept. 1.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Guilin Medical University

Condition: Malignant tumor

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-01

Target Sample Size: Experimental group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=322733

Disclaimer: Curated by HT Syndication....